Financialsexperimental

CSX CORP (CSX). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.

Income Statement Balance Sheet Cash FlowQuarterly Annual

USD in millions

Cash Flow	Q2 FY26 30 Jun 2026	Q1 FY26 31 Mar 2026	Q4 FY25 31 Dec 2025	Q3 FY25 30 Sept 2025	Q2 FY25 30 Jun 2025	Q1 FY25 31 Mar 2025	Q4 FY24 31 Dec 2024	Q3 FY24 30 Sept 2024	Q2 FY24 30 Jun 2024	Q1 FY24 31 Mar 2024	Q4 FY23 31 Dec 2023	Q3 FY23 30 Sept 2023	Q2 FY23 30 Jun 2023	Q1 FY23 31 Mar 2023	Q4 FY22 31 Dec 2022	Q3 FY22 30 Sept 2022	Q2 FY22 30 Jun 2022	Q1 FY22 31 Mar 2022	Q4 FY21 31 Dec 2021
Net Earnings	1,002*	807	720*	694*	829*	646	733*	894*	950*	893	886*	846*	996*	987	1,018*	1,111*	1,178*	859	934*
Depreciation																			360*
Depreciation and Amortization	411*	415	404*	424*	427*	425	422*	416*	410*	410	417*	399*	402*	393	393*	378*	369*	360
Deferred Income Taxes	33*	51	51*	144*	-14*	13	-7*	5*	3*	11	29*	33*	43*	35	-8*	19*	69*	37	58*
Goodwill Impairment (Note 18)			0*
Other Operating Activities	-24*	-47	-12*	-8*	-46*	-4	-29*	-25*	5*	-15	-74*	46*	54*	-31	35*	-38*	-18*	4	2*
Gains on Property Dispositions							-3*	1*	-8*	-1	-8*	-6*	-12*	-8	-55*	-27*	-129*	-27	-24*
Accounts Receivable	-70*	-120	118*	6*	-27*	-9	75*	26*	-24*	5	14*	-73*	71*	-63	42*	55*	-67*	-131	12*
Other Current Assets	53*	-38	-55*	-19*	21*	-34	18*	2*	54*	-29	-34*	19*	-33*	-72	10*	39*	-31*	-40	-21*
Accounts Payable	-10*	64	-61*	83*	-71*	89	-62*	99*	-114*	72	31*	72*	-90*	70	-26*	105*	-21*	82	-4*
Income and Other Taxes Payable	-106*	176	109*	-146*	-537*	175	129*	255*	-260*	-143	164*	234*	-233*	266	-61*	-21*	-182*	225	-102*
Other Current Liabilities	38*	-36	112*	-5*	53*	-46	4*	13*	73*	-119	75*	-4*	34*	-326	16*	104*	63*	-70	65*
Net Cash Provided by Operating Activities	1,327*	1,272	1,386*	1,337*	635*	1,255	1,388*	1,686*	1,089*	1,084	1,500*	1,566*	1,232*	1,251	1,364*	1,725*	1,231*	1,299	1,280*
Property Additions	-576*	-543	-677*	-730*	-776*	-719	-838*	-625*	-542*	-524	-691*	-575*	-572*	-443	-696*	-626*	-480*	-331	-571*
Purchases of Short-Term Investments	-375*	-140					-66*	-0*	-0*	-0	-1*	-1*	-1*	-101	-40*	-0*	-0*	-19	-75*
Proceeds from Sales of Short-term Investments	141*	5	8*	3*	2*	67	10*	0*	0*	81	0*	0*	100*	53	0*	0*	9*	0	2*
Proceeds and Advances from Property Dispositions	73*	64	14*	15*	26*	23	16*	7*	43*	0	17*	0*	27*	8	195*	22*	21*	8	232*
Business Acquisition, Net of Cash Acquired			1*	1*	14*	0	2*	18*	24*	26	0*	0*	29*	2	4*	15*	199*	9	-2*
Other Investing Activities	-17*	47	-50*	22*	-45*	-18	-3*	-38*	-21*	-35	-57*	1*	-25*	5	58*	-6*	-2*	-17	-4*
Net Cash Used In Investing Activities	-754*	-567	-706*	-691*	-807*	-647	-883*	-674*	-544*	-504	-732*	-575*	-500*	-480	-487*	-625*	-651*	-368	-414*
Shares Repurchased	-296*	-222	-112*	-112*	-421*	-751	-1,025*	-402*	-563*	-247	-581*	-971*	-863*	-1,067	-1,021*	-1,195*	-1,499*	-1,016	-570*
Dividends Paid	-260*	-260	-242*	-242*	-243*	-245	-230*	-232*	-233*	-235	-216*	-218*	-222*	-226	-207*	-212*	-215*	-218	-206*
Long-term Debt Repaid (Note 7)	-7*	-2	-601*	-9*	-1*	-2	-2*	-552*	-2*	-2	-3*	-4*	-4*	-142	-8*	-85*	-87*	-6	-36*
Long-term Debt Issued (Note 7)	0*	0	300*	0*	0*	600	0*				0*				0*				0*
Other Financing Activities	33*	73	33*	-58*	85*	-4	41*	30*	8*	34	25*	6*	22*	-3	6*	-21*	9*	6	6*
Net Cash Used in Financing Activities	-530*	-411	-622*	-421*	-580*	-402	-1,216*	-606*	-790*	-450	-775*	-587*	-1,067*	-1,438	-1,230*	487*	-1,792*	-1,234	-806*
Net Increase (Decrease) in Cash and Cash Equivalents	43*	294	58*	225*	-752*	206	-711*	406*	-245*	130	-7*	404*	-335*	-667	-353*	1,587*	-1,212*	-303	60*
Cash and Cash Equivalents at Beginning of Period	964*	670	612*	387*	1,139*	933	1,644*	1,238*	1,483*	1,353	1,360*	956*	1,291*	1,958	2,311*	724*	1,936*	2,239	2,179*
Cash and Cash Equivalents at End of Period	1,007	964	670	612	387	1,139	933	1,644	1,238	1,483	1,353	1,360	956	1,291	1,958	2,311	724	1,936	2,239
Issuance of Common Stock as Consideration for Acquisition											0*	0*			0*	0*